Dyspepsia in childhood and adolescence: Insights and treatment considerations

Current Gastroenterology Reports

Volumn 9, Issue 6, 2007, Pages 447-455

  Perez, Maria E ^b   Youssef, Nader N ^a  

^a Atlantic Health   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALOSETRON; AMITRIPTYLINE; ANGELICA EXTRACT; ANTIBIOTIC AGENT; BETHANECHOL; CARAWAY EXTRACT; CHAMOMILE; CIMETIDINE; CISAPRIDE; DOMPERIDONE; ERYTHROMYCIN; FAMOTIDINE; GINGER EXTRACT; GLYCYRRHIZA EXTRACT; GRANISETRON; IBEROGAST; LANSOPRAZOLE; METOCLOPRAMIDE; MONTELUKAST; MOTILIN; NUTRACEUTICAL; OMEPRAZOLE; ONDANSETRON; PANTOPRAZOLE; PEPPERMINT; PLACEBO; PLANT EXTRACT; RANITIDINE; SEROTONIN; TEGASEROD; UNINDEXED DRUG; 2 [[(2 PYRIDYL)METHYL]SULFINYL]BENZIMIDAZOLE DERIVATIVE; ACETIC ACID DERIVATIVE; LEUKOTRIENE RECEPTOR BLOCKING AGENT; PROTON PUMP INHIBITOR; QUINOLINE DERIVATIVE;

ABDOMINAL PAIN; ABDOMINAL RADIOGRAPHY; ACUPUNCTURE; ADOLESCENT; ANALGESIA; ANGELICA; ANXIETY; BEDTIME DOSAGE; CARAWAY; CARDIOVASCULAR DISEASE; CENTRAL NERVOUS SYSTEM FUNCTION; CHILD; CHILD CARE; CLINICAL TRIAL; COGNITIVE THERAPY; COMORBIDITY; DEPRESSION; DIET RESTRICTION; DISEASE ASSOCIATION; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DYSPEPSIA; EPIGASTRIC DISCOMFORT; EPIGASTRIC FULLNESS; ERADICATION THERAPY; FEEDBACK SYSTEM; GASTROINTESTINAL ENDOSCOPY; GASTROINTESTINAL MOTILITY; GINGER; GLYCYRRHIZA; GUIDED IMAGERY; HELICOBACTER PYLORI; HUMAN; HYPNOSIS; INFORMATION PROCESSING; INTESTINE TRANSIT TIME; IRRITABLE COLON; LOW DRUG DOSE; LOW FAT DIET; MENTAL DISEASE; MENTHA PIPERITA; NAUSEA; NONHUMAN; PAIN ASSESSMENT; PATHOPHYSIOLOGY; REVIEW; SOCIAL PSYCHOLOGY; STOMACH EMPTYING; STOMACH SCINTISCANNING; SYMPTOM; YOGA; ANIMAL; DRUG EFFECT; HELICOBACTER INFECTION; INNERVATION; PHYSIOLOGY; PHYTOTHERAPY; PSYCHOLOGICAL ASPECT; PSYCHOTHERAPY; STOMACH; VISCERA;

2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES; ABDOMINAL PAIN; ACETATES; ACUPUNCTURE THERAPY; ADOLESCENT; ANIMALS; CHILD; COGNITIVE THERAPY; DYSPEPSIA; ENDOSCOPY, GASTROINTESTINAL; GASTRIC EMPTYING; GASTROINTESTINAL MOTILITY; GINGER; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; HYPNOSIS; IMAGERY (PSYCHOTHERAPY); LEUKOTRIENE ANTAGONISTS; PHYTOTHERAPY; PLANT EXTRACTS; PROTON PUMP INHIBITORS; QUINOLINES; SEROTONIN; STOMACH; VISCERA;

EID: 44249087453     PISSN: 15228037     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11894-007-0058-4     Document Type: Review

References (78)

1. Castillo EJ, Camilleri M, Locke GR, et al.: A community based controlled study of the epidemiology and pathophysiology of dyspepsia. Clin Gastroenterol Hepatol 2004, 2:985-996.
2. Drossman DA, Li Z, Andruzzi E, et al.: US householder survey of functional gastrointestinal disorders: prevalence, sociodemography, and health impact. Dig Dis Sci 1993, 38:1569-1580.
3. Shaffer SE, Sellman SB, Repucci AN, et al.: Dyspepsia: redefining chronic abdominal pain in children. Gastroenterology 1992, 102:103A.
4. Thomson AB, Barkun AN, Armstrong D: The prevalence of clinically significant endoscopic findings in primary care patients with uninvestigated dyspepsia: the Canadian adult dyspepsia empiric treatment and prompt endoscopy. Aliment Pharmacol Ther 2003, 17:1481-1491.
5. Drossman DA: The functional gastrointestinal disorders and the Rome III process. Gastroenterology 2006, 130:1377-1390.
6. Hyams JS, Burke G, Davis PM, et al.: Abdominal pain and IBS in adolescents: a community based study. J Pediatr 1996, 129:220-226.
7. Hyams JS, Davis P, Sylvester FA, et al.: Dyspepsia in children and adolescents: a prospective study. J Pediatr Gastroenterol Nutr 2000, 30:413-418.
8. Jones MP, Maganti K: Symptoms, gastric function, and psychosocial factors in functional dyspepsia. J Clin Gastroenterol 2004, 38:866-872.
9. Koloski NA, Talley NJ, Huskic SS, Boyce PM: Predictors of conventional and alternative health care seeking for irritable bowel syndrome and functional dyspepsia. Aliment Pharmacol Ther 2003, 17:841-851.
10. Talley NJ, Boyce P, Jones M: Dyspepsia and health care seeking in a community: how important are psychological factors? Dig Dis Sci 1998, 43:1016-1022.
11. Anand KJ, Coskun V, Thrivikraman KV: Long term behavioral effects of repetitive pain in neonatal rat pups. Physiol Behav 1999,66:627-637.
12. Friesen CA, Lin Z, Garola R, et al.: Chronic gastritis is not associated with gastric dysrhythmia or delayed solid emptying in children with dyspepsia. Dig Dis Sci 2005, 50:1012-1018.
13. Wo JM, Parkman HP: Motility and functional disorders of the stomach: diagnosis and management of functional dyspepsia and gastroparesis. Pract Gastroenterol 2006; 4:23-48.
14. Read NW: Food and hypersensitivity in FD. Gut 2002, 51: i50-i53.
15. Kim DY, Myung SJ, Camilleri M: Novel testing of human gastric motor and sensory functions: rationale, methods, and potential applications in clinical practice. Am J Gastroenterol 2000, 95:3365-3373.
16. Kuiken SD, Samson M, Camilleri M: Development of a test to measure gastric accommodation in humans. Am J Physiol 1999, 277:G1217-G1221.
17. De Schepper HU, Cremonini F, Chitkara D, Camilleri M: Assessment of gastric accommodation: overview and evaluation of current methods. Neurogastroenterol Motil 2004, 16:275-285.
18. Thumshirn M, Camilleri M, Saslow SB, et al.: Gastric accommodation in non-ulcer dyspepsia and the roles of Helicobacter pylori infection and vagal function. Gut 1999, 44:55-64.
19. Thumshirn M: Pathophysiology of functional dyspepsia. Gut 2002, 51(Suppl 1):i63-i66.
20. Samson M, Salet GA, Roelof SJ, et al.: Compliance of the proximal stomach and dyspeptic symptoms in patients with type I diabetes mellitus. Dig Dis Sci 1995, 40:2037-2042.
21. Karamanopolis G, Caenepeel P, Arts J, Tack J: Association of the predominant symptom with clinical characteristics and pathophysiology mechanisms in functional dyspepsia. Gastroenterology 2006, 130:296-303.
22. Hoffman I, Vos R, Tack J: Assessment of gastric sensorimotor function in pediatrics patients with unexplained dyspeptic symptoms and poor weight gain. Neurogastroenterol Motil 2007, 19:173-179.
23. Chitkara DK, Delgado-Aros S, Bredenoord AJ, et al.: Functional dyspepsia, upper gastrointestinal symptoms, and transit in children. J Pediatr 2003, 143:609-613.
24. Di Lorenzo C, Youssef NN, Sigurdsson L, et al.: Visceral hyperalgesia in children with functional abdominal pain. J Pediatr 2001, 139:838-843.
25. Kandula L, Lowe ME, Khan S, et al.: Clinical vignettes. Am J Gastroenterol 1997, 9(Suppl):S217.
26. Tack J, Caenepeel P, Corserti M, Janssens J: Role of tension receptors in dyspeptic patients with hypersenstivity to gastric distension. Gastroenterology 2004, 127:1058-1066.
27. Riezzo G, Chidoiro M, Guerra V, et al.: Comparison of gastric electrical activity and gastric emptying in healthy and dyspeptic children. Dig Dis Sci 2000, 45:517-524.
28. Lin Z, Eaker EY, Sarosicki J, McCallum RW: Gastric myoelectrical activity and gastric emptying in patient with FD. Am J Gastroenterol 1999, 94:1023-1028.
29. Stanghellini V, Tosetti C, Paternico A: Risk factors of delayed gastric emptying of solids in patients with functional dyspepsia. Gastroenterology 1996, 10:1036-1042.
30. Talley NJ, Locke GR, Lahr BD, et al.: FD, delayed gastric emptying, and impaired quality of life. Gut 2006, 55:933-939.
31. Kellow JE, Aspiroz F, Delvaux M, et al.: Applied principles of neurogastroenterology: physiology/motility sensation. Gastroenterology 2006, 130:1412-1420.
32. Pace F, Zuin G, DiGiacomo S, et al.: Family history of irritable bowel syndrome is the major determinant of persistent abdominal complaints in young adults with a history of pediatric recurrent abdominal pain. World J Gastroenterol 2006, 12:3874-3877.
33. Kleibeuker JH, Thijs JC: Functional dyspepsia. Curr Opin Gastroenterol 2004, 20:546-550.
34. Rasquin-Weber A, Hyman PE, Cucchiara S, et al.: Childhood functional gastrointestinal disorders. Gut 1999,45:1160-1168.
35. Talley NJ: Guidelines for management of dyspepsia. Am J Gastroenterol 2005, 100:2324-2337.
36. Talley NJ: How to manage the difficult-to-treat dyspeptic patient. Nat Clin Pract Gastroenterol Hepatol 2007, 4:35-42.
37. Chiba N, DeGara CJ, Wilkinson JM: Speed of healing and symptorn relief in grade II to IV gastroesophageal reflux disease: a meta analysis. Gastroenterology 1997, 112:1798-1810.
38. McCarty-Dawson D, Sue SO, Morrill B, Murdeck RH, Jr: Ranitidine versus cimetidine in the healing of erosive esophagitis. Clin Ther 1996, 18:1150-1160.
39. Stacey JH, Miocevich ML, Sacks GE: The effect of ranitidine (as effervescent tablets) on the quality of life of GERD patients. Br J Clin Pract 1996, 50:190-194.
40. See MC, Birnbaum AH, Schechter CB, et al.: Double-blinded, placebo controlled trial of famotidine in children with abdominal pain and dyspepsia: global and quantitative assessment. Dig Dis Sci 2001, 46:985-992.
41. Kanjoo M, Kane R: Omeprazole treatment of children with peptic esophagitis refractory to ranitidine therapy. Arch Pediatr Adolesc Med 1995, 149:267-271.
42. Kato S, Ebina K, Fujii K, et al.: Effect of omeprazole in the treatment of refractory acid-related diseases in childhood: endoscopic healing and twenty four hour intragastric acidity. J Pediatr 1996, 128:415-421.
43. De Giacomo C, Bawa P, Franceschi M: Omeprazole for severe reflux esophagitis in children. J Pediatr Gastroenterol Nutr 1997, 24:528-532.
44. Strauss RS, Calenda KA, Dayal Y: Histological esophagitis: clinical and histological response to omeprazole in children. Dig Dis Sci 1999,44:134-139.
45. Croom KF, Scott LJ: Lansoprazole in the treatment of gastroesophageal reflux disease in children and adolescents. Drugs 2005, 65:2129-2135.
46. Tsou VM, Baker R, Book L, et al.: Multicenter, randomized, double blind study comparing 20 and 40mg pantoprazole for symptom relief in adolescents (12 to 16 years old) with GERD. Clin Pediatr 2006, 45:741-749.
47. Euler AR: Use of bethanechol for the treatment of gastroesophageal reflux. J Pediatr 1980, 96:321-324.
48. DeLoore I, Van Ravensteyn H, Ameryckx L: Domperidone drops in the symptomatic treatment of chronic pediatric vomiting and regurgitation. A comparison with metoclopramide. Postgrad Med J 1979, 55:40-42.
49. Bines JE, Quinlan JE, Treves S, et al.: Efficacy of domperidone in infants and children with gastroesophageal reflux. J Pediatr Gastroenterol Nutr 1992, 14:400-405.
50. Curry JI, Lander TD, Stringer MD: Review article: erythromycin as a prokinetic agent in infants and children. Aliment Pharmacol Ther 2001, 15:595-603.
51. Gershon MD, Tack J: The serotonin signaling system: from basic understanding to drug development for functional GI disorders. Gastroenterology 2007, 1:397-414.
52. Mertz H, Fass R, Kodner A, et al.: Effect of amitriptyline on symptoms, sleep, and visceral perception in patients with functional dyspepsia. Am J Gastroenterol 1998, 2:160-165.
53. Humphreys PA, Gervirtz RN: Treatment of recurrent abdominal pain: components analysis of four treatment protocols. J Pediatr Gastroenterol Nutr 2000, 31:47-51.
54. Robins PM, Smith SM, Glutting JJ, Bishop CT: A randomized controlled trial of cognitive-behavioral family intervention for pediatric recurrent abdominal pain. J Pediatr Psychol 2005, 30:397-408.
55. Heymann-Monnikes I, Arnold R, Florin I, et al.: The combination of medical treatment plus multi-component behavioral therapy is superior to medical treatment alone in the therapy of irritable bowel syndrome. Am J Gastroenterol 2000, 95:981-994.
56. Youssef NN, Rosh JR, Loughan M, et al.: Treatment of functional abdominal pain in childhood with cognitive behavioral strategies. J Pediatr Gastroenterol Nutr 2004, 39:192-196.
57. Weydert JA, Shapiro DE, Acra SA, et al.: Evaluation of guided imagery as treatment for recurrent abdominal pain in children: a randomized controlled trial. BMC Pediatrics 2006, 6:29.
58. Calvert EL, Houghton LA, Cooper P: Long term improvement in functional dyspepsia using hypnotherapy. Gastroenterology 2002, 123:1778-1785.
59. van Tilburg MA, Palsson OS, Turner M, et al.: Self administered guided imagery used at home is an effective treatment for FAP in children. Gastroenterology 2007, 132:A-319.
60. Vlieger A, Menko-Frankenhuis C, Wolfkamp SC, et al.: Hypnotherapy for children with functional abdominal pain or irritable bowel syndrome: a randomized controlled trial. Gastroenterology 2007, 132:A-914.
61. Kuttner L, Chambers CT, Hardial J, et al.: A randomized trial of yoga for adolescents with irritable bowel syndrome. Pain Res Manag 2006, 11:217-223.
62. Ghayur MN, Gilani AH: Pharmacological basis for the medicinal use of ginger in gastrointestinal disorders. Dig Dis Sci 2005, 10:1889-1897.
63. Micklefield GH, Redeke Y, Meister V, et al.: Effects of ginger on gastroduodenal motility. Int J Clin Pharmacol Ther 1999, 7:341-346.
64. Schemann M, Michael K, Zeller F, et al.: Region-specific effects of STW 5 (Iberogast) and its components in gastric fundus, corpus and antrum. Phytomedicine 2006, 13(Suppl 5):90-99.
65. Pilichiewicz AN, Hoowitz M, Russo A, et al.: Effects of Iberogast on proximal gastric volume, antropyloroduodenal motility and gastric emptying in healthy men. Am J Gastroenterol 2007, 6:1276-1283.
66. Ezzo J, Streiberger K, Schneider A: Cochrane systematic reviews examine P6 acupuncture-point stimulation for nausea and vomiting. J Altern Complement Med 2006, 5:489-495.
67. Xu S, Hou X, Zha H, et al.: Electroacupuncture accelerates solid gastric emptying and improves dyspeptic symptoms in patients with functional dyspepsia. Dig Dis Sci 2006, 51:2154-2159.
68. Friesen CA, Sandridge L, Andre L, Roberts CC: Mucosal eosinophils and response to H1/H2 antagonist and cromolyn therapy in pediatric dyspepsia. Clin Pediatr (Phila) 2006, 45:143-147.
69. Talley NJ, Walker MM, Aro P, et al.: Duodenal eosinophilia and mast cell infiltration in FD and IBS: duodenal eosinophilia a biomarker for FD but not IBS in adults? Gastroenterology 2007, 132: A73.
70. Friesen CA, Andre L, Garola R, et al.: Activated duodenal mucosal eosinophils in children with dyspepsia: a pilot transmission electron microscopic study. J Pediatr Gastroenterol Nutr 2002, 35:329-333.
71. Friesen CA, Kearns GL, Andre L, et al.: Clinical efficacy and pharmacokinetics of montelukast in dyspeptic children with duodenal eosinophilia. J Pediatr Gastroenterol Nutr 2004, 38:343-351.
72. Sherman PM, Lin FY: Extradigestive manifestations of Helicobacter pylori infection in children and adolescents. Can J Gastroenterol 2005, 19:421-424.
73. Gold BD, Colletti RB, Abbott M: Helicobacter pylori infection in children: recommendations for diagnosis and treatment. J Pediatr Gastroenterol Nutr 2000, 31:490-497.
74. Drumm B, Koletzko S, Oderda G: Helicobacter pylori infection in children: a consensus statement, European Pediatric Task Force on H. pylori. J Pediatr Gastroenterol Nutr 2000, 30:207-213.
75. Kalach N, Mention K, Guimber D, et al.: Helicobacter pylori infection is not associated with specific symptoms in NUD children. Pediatrics 2005, 155:17-21.
76. Farrell ST: Non-ulcer dyspepsia and Helicobacter pylori eradication in children. J Pediatr Surg 2005, 40:1547-1550.
77. Sood MR, Joshi S, Akobeng AK, et al.: Growth in children with Helicobacter pylori infection and dyspepsia. Arch Dis Child 2005, 90:1025-1028.
78. Xia HH, Talley NJ: Helicobacter pylori eradication in patients with non-ulcer dyspepsia. Drugs 1999, 58:785-792.